Literature DB >> 9331925

Changes in the alpha 2-adrenergic receptor subtypes gene expression in rat dorsal root ganglion in an experimental model of neuropathic pain.

H J Cho1, D S Kim, N H Lee, J K Kim, K M Lee, K S Han, Y N Kang, K J Kim.   

Abstract

We examined changes in expression of genes coding for alpha 2-AR subtypes in the dorsal root ganglion (DRG) in a rat model (spinal nerve ligation) or neuropathic pain. The present study demonstrates that the majority of DRG neurons express alpha 2C-AR mRNA and a small proportion of neurons express alpha 2A-AR mRNA, while few neurons express alpha 2B-AR mRNA in non-operated animals. In addition, alpha 2C- and alpha 2A mRNA levels in the DRG showed a significant decrease and increase, respectively in ligated animals. These findings suggest that alpha 2A- and alpha 2C-ARs in the DRG may play an important role in generating sympathetically maintained neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331925     DOI: 10.1097/00001756-199709290-00022

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

1.  No adrenergic sensitization of afferent neurons in painful sensory polyneuropathy.

Authors:  Jörn Schattschneider; Jens Uphoff; Andreas Binder; Gunnar Wasner; Ralf Baron
Journal:  J Neurol       Date:  2005-09-15       Impact factor: 4.849

2.  Contribution of alpha(2) receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidine.

Authors:  A B Malmberg; L R Hedley; J R Jasper; J C Hunter; A I Basbaum
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

3.  Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons.

Authors:  Saikat Chakraborty; Vincent Elvezio; Martin Kaczocha; Mario Rebecchi; Michelino Puopolo
Journal:  J Physiol       Date:  2017-02-22       Impact factor: 5.182

4.  The transient receptor potential channel TRPM8 is inhibited via the alpha 2A adrenoreceptor signaling pathway.

Authors:  Alexis Bavencoffe; Dimitra Gkika; Artem Kondratskyi; Benjamin Beck; Anne-Sophie Borowiec; Gabriel Bidaux; Jérôme Busserolles; Alain Eschalier; Yaroslav Shuba; Roman Skryma; Natalia Prevarskaya
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

5.  Does norepinephrine influence pain behavior mediated by dorsal root ganglia?: a pilot study.

Authors:  Katsumasa Tanimoto; Tsuneo Takebayashi; Takeshi Kobayashi; Noritsugu Tohse; Toshihiko Yamashita
Journal:  Clin Orthop Relat Res       Date:  2011-02-11       Impact factor: 4.176

6.  Dietary sodium modulates the interaction between efferent and afferent renal nerve activity by altering activation of α2-adrenoceptors on renal sensory nerves.

Authors:  Ulla C Kopp; Michael Z Cicha; Lori A Smith; Saku Ruohonen; Mika Scheinin; Nicolas Fritz; Tomas Hökfelt
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-24       Impact factor: 3.619

7.  Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.

Authors:  S Sawamura; W S Kingery; M F Davies; G S Agashe; J D Clark; B K Kobilka; T Hashimoto; M Maze
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

Review 8.  Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis.

Authors:  Carolyn A Fairbanks; Laura S Stone; George L Wilcox
Journal:  Pharmacol Ther       Date:  2009-04-23       Impact factor: 12.310

9.  Sympathetic vasoconstrictor antagonism and vasodilatation relieve mechanical allodynia in rats with chronic postischemia pain.

Authors:  Dimitris N Xanthos; Terence J Coderre
Journal:  J Pain       Date:  2008-02-11       Impact factor: 5.820

10.  Dexmedetomidine Inhibits ASIC Activity via Activation of α2A Adrenergic Receptors in Rat Dorsal Root Ganglion Neurons.

Authors:  Shuang Wei; Chun-Yu Qiu; Ying Jin; Ting-Ting Liu; Wang-Ping Hu
Journal:  Front Pharmacol       Date:  2021-05-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.